Beijing Tsinghua Chang Gung Hospital: Carcinoma, Hepatocellular trials

The registry lists 17 Carcinoma, Hepatocellular studies with Beijing Tsinghua Chang Gung Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 2No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• AI-Assisted Staging and Treatment Decision-Making for Hepatocellular CarcinomaRecruitingNCT07538882
• Digital Early Warning System for Acute Lung Injury in Liver SurgeryRecruitingNCT07070362
• Downstaging Prediction Model for HCCNot yet recruitingNCT07058649
• AI-Driven Quantitative Decision and Surgical Planning System for Liver CancerEnrolling by invitationNCT07042841
• Relationship Between FGF19 Overexpression and Disease PrognosisNot yet recruitingNCT06938451
• Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTTRecruitingNCT05225116Phase 1
• Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;RecruitingNCT04738188Not applicable
• Real-world Study of Lenalidomide After First-line Treatment Lenvatinib With PD-1 in Advanced HCCCompletedNCT07184424Not applicable
• Calculator Predicts Early Mortality Post Hepatocellular Carcinoma ResectionCompletedNCT06621485
• Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision TreeStatus unknownNCT05986383
• Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver TransplantationStatus unknownNCT05576909Phase 2
• Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular CarcinomaStatus unknownNCT05411926
• Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in the Treatment of Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT)Status unknownNCT04619342Not applicable
• Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in Treatment of Huge Hepatocellular Carcinoma (HCC) (≥10cm)Status unknownNCT04619329Not applicable
• Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver CancerStatus unknownNCT04523662Phase 2
• GPC3-CAR-T Cells for the Hepatocellular CarcinomaSuspendedNCT04506983Phase 1
• Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor ThrombosisStatus unknownNCT04104074Phase 1